Tumor infiltrating lymphocytes (TILs): Lessons learned in 30 years of study

American Cancer Society Website. 2004. Hughes, 1988, Resection of the liver for colorectal-carcinoma metastases: a multi-institutional study of indications for resection, Surgery, 103, 278 Foley, 1953, Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin, Cancer Res, 13, 835 Smith, 2004, Cytokine gene polymorphisms and breast cancer susceptibility and prognosis, Eur J Immunogenet, 31, 167, 10.1111/j.1365-2370.2004.00462.x Loktionov, 2004, Common gene polymorphisms, cancer progression and prognosis, Cancer Lett, 208, 1, 10.1016/j.canlet.2004.02.009 Martin, 2003, Population frequencies of single nucleotide polymorphisms (SNPs) in immuno-modulatory genes, Hum Hered, 55, 171, 10.1159/000073201 Nakamura, 2002, Genetic polymorphisms of the interleukin-4 receptor alpha gene are associated with an increasing risk and a poor prognosis of sporadic renal cell carcinoma in a Japanese population, Clin Cancer Res, 8, 2620 Calhoun, 2002, Host genetic polymorphism analysis in cervical cancer, Clin Chem, 48, 1218, 10.1093/clinchem/48.8.1218 Brasseur, 1992, Human gene MAGE-1, which codes for a tumor-rejection antigen, is expressed by some breast tumors, Int J Cancer, 52, 839, 10.1002/ijc.2910520528 Sahin, 2000, Expression of cancer testis genes in human brain tumors, Clin Cancer Res, 6, 3916 Murray, 1975, Prognosis in colon cancer: a pathologic reassessment, Arch Surg, 110, 908, 10.1001/archsurg.1975.01360140052011 Sheu, 1999, Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma, Cancer, 86, 1537, 10.1002/(SICI)1097-0142(19991015)86:8<1537::AID-CNCR21>3.0.CO;2-D Mann, 2002, FasL is more frequently expressed in liver metastases of colorectal cancer than in matched primary carcinomas, Br J Cancer, 79, 1262, 10.1038/sj.bjc.6690202 Okada, 2000, Frequency of apoptosis of tumor-infiltrating lymphocytes induced by fas counterattack in human colorectal carcinoma and its correlation with prognosis, Clin Cancer Res, 6, 3560 Bennett, 1998, The fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with fas ligand expression by human esophageal carcinoma, J Immunol, 160, 5669, 10.4049/jimmunol.160.11.5669 Fisk, 1997, Identification of naturally processed human ovarian peptides recognized by tumor-associated CD 8+ cytotoxic T lymphocytes, Cancer Res, 57, 87 Linehan, 1995, Tumor-specific and HLA-A2-restricted cytolysis by tumor associated lymphocytes in human metastatic breast cancer, J Immunol, 155, 4486, 10.4049/jimmunol.155.9.4486 Puccetti, 2002, Role of low nuclear grading of renal carcinoma cells in the functional profile of tumor-infiltrating T cells, Int J Cancer, 98, 674, 10.1002/ijc.10238 Groh, 1999, Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICE, Proc Natl Acad Sci U S A, 96, 6879, 10.1073/pnas.96.12.6879 Michael-Robinson, 2001, Tumour infiltrating lymphocytes and apoptosis are independent features in colorectal cancer stratified according to microsatellite instability status, Gut, 48, 360, 10.1136/gut.48.3.360 Calhoun, 2000, Evidence for cytotoxic T lymphocyte response against human lung cancer: Reconstitution of antigenic epitope with peptide eluted from lung adenocarcinoma MHC class I, Surgery, 128, 76, 10.1067/msy.2000.106639 Schumacher, 2001, Prognostic significance of activated CD8+ T cell infiltrations within esophageal carcinomas, Cancer Res, 61, 3932 Fukuzawa, 2001, Expression of Fas/Fas ligand (FasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma, J Gastroenterol, 36, 681, 10.1007/s005350170031 Zietz, 2001, Inverse relation of fas-ligand and tumor-infiltrating lymphocytes in angiosarcanoma, Am J Pathol, 159, 963, 10.1016/S0002-9440(10)61772-5 Murthy, 2000, Risk factors for pre-cancerous lesions of the cervix, Eur J Cancer Prev, 9, 5, 10.1097/00008469-200002000-00002 Lothe, 1993, Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history, Cancer Res, 53, 5849 Wright, 2000, The prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer, Br J Surg, 87, 1197, 10.1046/j.1365-2168.2000.01508.x Reichert, 2001, The number of intratumoral dendritic cells and ζ-chain expression in T Cells as prognostic and survival biomarkers in patients with oral carcinoma, Cancer, 91, 2136, 10.1002/1097-0142(20010601)91:11<2136::AID-CNCR1242>3.0.CO;2-Q Zeid, 1993, S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival, Pathology, 25, 338, 10.3109/00313029309090853 Kenji, 1989, S-100 protein-positive dendritic cells in colorectal adenocarcinomas, Cancer, 63, 496, 10.1002/1097-0142(19890201)63:3<496::AID-CNCR2820630318>3.0.CO;2-K Tsujitani, 1993, Dendritic cells prevent lymph node metastasis in patients in gastric cancer, In Vivo, 7, 233 Goldman, 1998, Peritumoral CD1a-positive dendritic cells are associated with improved survival in patients with tongue carcinoma, Arch Otolaryngol Head Neck Surg, 124, 641, 10.1001/archotol.124.6.641 Ishigama, 2002, CD3-ζ chain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients, Cancer, 94, 1437, 10.1002/cncr.10346 Schwaab, 2001, Dendritic cell infiltration in colon cancer, J Immunother, 24, 130, 10.1097/00002371-200103000-00007 Dallal, 2002, Paucity of dendritic cells in pancreatic cancer, Surgery, 131, 135, 10.1067/msy.2002.119937 Tanaka, 2000, Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells, Cancer Res, 60, 4838 Tatsumi, 2003, Intratumoral delivery of dendritic cells engineered to secrete both interleukin (IL)-12 and IL-18 effectively treats local and distant disease in association with broadly reactive Tc1-type immunity, Cancer Res, 2003, 6378 Suzuki, 2002, Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma, J Pathol, 196, 37, 10.1002/path.1018 Wang, 2002, Induction of CD4+ T cell-dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells, J Clin Invest, 109, 1463, 10.1172/JCI200215399 Sloan, 2002, MHC class I and class II presentation of tumor antigen in retrovirally and adenovirally transduced dendritic cells, Cancer Gene Ther, 9, 946, 10.1038/sj.cgt.7700509 Kershaw, 2001, Immunization against endogenous retroviral tumor-associated antigens, Cancer Res, 61, 7920 Chen, 2003, Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor of Foxp3, J Exp Med, 198, 1875, 10.1084/jem.20030152 Sakaguchi, 1995, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases, J Immunol, 155, 1151, 10.4049/jimmunol.155.3.1151 Shimizu, 1999, Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity, J Immunol, 163, 5211, 10.4049/jimmunol.163.10.5211 Ichihara, 2003, Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers, Clin Cancer Res, 9, 4404 Wolf, 2003, Increase of regulatory T cells in the peripheral blood of cancer patients, Clin Cancer Res, 9, 606 Thornton, 1998, CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro and by inhibiting interleukin 2 production, J Exp Med, 188, 289, 10.1084/jem.188.2.287 Nelson, 2004, IL-2, regulatory T cells, and tolerance, J Immunol, 172, 3983, 10.4049/jimmunol.172.7.3983 Wei, 2004, Anti-tumor immunity and autoimmunity: a balancing act of regulatory T cells, Cancer Immunol Immunother, 53, 73, 10.1007/s00262-003-0444-1 Griffith, 1995, Fas ligand-induced apoptosis as a mechanism of immune privilege, Science, 270, 1189, 10.1126/science.270.5239.1189 Restifo, 2000, Not so Fas: re-evaluating the mechanisms of immune privilege and tumor escape, Nat Med, 6, 493, 10.1038/74955 Michael-Robinson, 2003, Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status, J Pathol, 201, 46, 10.1002/path.1406 Hahne, 1996, Melanoma cell expression of Fas (APO-1/CD95) ligand: implications for tumor escape, Science, 274, 1363, 10.1126/science.274.5291.1363 Lim, 2003, Fas-related apoptosis in gastric adenocarcinoma, Oncol Rep, 10, 57 Bodey, 1999, Fas (APO-1, CD95) receptor expression and new options for immunotherapy in childhood medulloblastomas, Anticancer Res, 19, 3293 O'Connell, 1996, The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand, J Exp Med, 184, 1075, 10.1084/jem.184.3.1075 O'Connell, 1998, Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer, J Pathol, 186, 240, 10.1002/(SICI)1096-9896(199811)186:3<240::AID-PATH173>3.0.CO;2-L Liu, 2000, Expression of fas ligand on bile ductule epithelium in biliary atresia—a poor prognostic factor, J Pediatr Surg, 35, 1591, 10.1053/jpsu.2000.18322 Yoong, 1999, Fas/Fas ligand interaction in human colorectal hepatic metastases, Am J Pathol, 154, 693, 10.1016/S0002-9440(10)65316-3 O'Connell, 1999, Expression of fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege, Clin Diagn Lab Immunol, 6, 457, 10.1128/CDLI.6.4.457-463.1999 Bennett, 1999, Expression of fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer, Gut, 44, 156, 10.1136/gut.44.2.156 Asanuma, 2004, Survivin enhances fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells, J Immunol, 172, 3922, 10.4049/jimmunol.172.6.3922 Houston, 2003, Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-β expression, Br J Cancer, 89, 1345, 10.1038/sj.bjc.6601240 Chen, 1998, Regulation of the proinflammatory effects of Fas ligand (CD95), Science, 282, 1714, 10.1126/science.282.5394.1714 Biroccio, 2001, c-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer, Am J Pathol, 158, 1289, 10.1016/S0002-9440(10)64080-1 Johnson, 1989, De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis, Proc Natl Acad Sci U S A, 86, 641, 10.1073/pnas.86.2.641 Maeda, 2002, Expression of intercellular adhesion molecule-1 and prognosis in colorectal cancer, Oncol Rep, 9, 511 Natali, 1997, Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions, Cancer Res, 57, 1554 Koyama, 1992, Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma, J Cancer Res Clin Oncol, 118, 609, 10.1007/BF01211806 Kitayama, 1999, Functional expression of β1 and β2 integrins on tumor infiltrating lymphocytes (TILs) in colorectal cancer, J Gastroenterol, 34, 327, 10.1007/s005350050269 Lippman, 1990, Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course, Mod Pathol, 3, 361 Stopeck, 2000, Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma, Clin Cancer Res, 6, 3904 Horst, 1990, Adhesion molecules in the prognosis of diffuse large-cell lymphoma: expression of a lymphocyte homing receptor (CD44), LFA-1 (CD11a/18), and ICAM-1 (CD54), Leukemia, 4, 595 Medeiros, 1989, Expression of LFA-1 in non-Hodgkin's lymphoma, Cancer, 63, 255, 10.1002/1097-0142(19890115)63:2<255::AID-CNCR2820630209>3.0.CO;2-V Yuen, 2001, Expression of fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma, Cancer, 92, 2136, 10.1002/1097-0142(20011015)92:8<2136::AID-CNCR1555>3.0.CO;2-J Riedl, 1997, TGF-β1 promotes in vitro generation of dendritic cells by protecting progenitor cells from apoptosis, J Immunol, 158, 1591, 10.4049/jimmunol.158.4.1591 Dybedal, 1997, Transforming growth factor-β1 abrogates fas-induced growth suppression and apoptosis of murine bone marrow progenitor cells, Blood, 90, 2284, 10.1182/blood.V90.9.3395 De Paola, 2003, Restored T-cell activation mechanisms in human tumor-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2, Br J Cancer, 88, 320, 10.1038/sj.bjc.6600679 Tamm, 1994, Cell-adhesion-disrupting action of interleukin-6 in human ductal breast carcinoma cells, Proc Natl Acad Sci U S A, 91, 3329, 10.1073/pnas.91.8.3329 Tamm, 1994, E-cadherin distribution in interleukin 6-induced cell-cell separation of ductal breast carcinoma cells, Proc Natl Acad Sci U S A, 91, 4338, 10.1073/pnas.91.10.4338 Kanai, 2000, Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion, Br J Cancer, 82, 1717 Sheu, 2001, Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer, J Immunol, 167, 2972, 10.4049/jimmunol.167.5.2972 von Bernstorff, 2001, Systemic and local immunosuppression in pancreatic cancer patients, Clin Cancer Res, 7, 925s